Travaux scientifiques

Prof. Dr. Faysal Dane

278 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)

    Journal of Cancer Research and Clinical Oncology, 2013

    DOI 10.1007/s00432-013-1390-8 PMID 23400732 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  2. Analysis of resected gastric cancer in Turkish population.

    PubMed, 2013

    DOI 10.5754/hge11078 PMID 24298576 Texte intégral en libre accèsSource : OpenAlex

  3. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience

    Oncology Letters, 2013

    DOI 10.3892/ol.2013.1408 PMID 24137379 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  4. Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients

    Clinical & Translational Oncology, 2013

    DOI 10.1007/s12094-013-1047-8 PMID 23615982 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  5. Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: Retrospective analysis of 667 patients anatolian society of medical oncology

    Oncology (Switzerland), 2013

    DOI 10.1159/000336902 PMID 23392240 14 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  6. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14533 1 citation (OpenAlex) Source : OpenAlex

  7. Retrospective analysis of 178 patients with stage I rectum cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14662 Texte intégral en libre accèsSource : OpenAlex

  8. Nazofarenks kanserinin mastoid bölge rekürrensi: Nadir bir klinik tablonun tedavisi

    DergiPark (Istanbul University), 2013

    Source : OpenAlex

  9. Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)

    Journal of Chemotherapy, 2013

    DOI 10.1179/1973947813y.0000000147 PMID 24112786 33 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  10. The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14705 Texte intégral en libre accèsSource : OpenAlex

  11. Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group Trial

    Oncology, 2013

    DOI 10.1159/000355914 PMID 24247559 71 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  12. The benefit of whole brain reirradiation in patients with multiple brain metastases

    Radiation Oncology, 2013

    DOI 10.1186/1748-717x-8-186 PMID 23879889 27 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  13. Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience

    Breast Care, 2013

    DOI 10.1159/000346829 PMID 24715846 24 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  14. Efficacy and Safety of Concomitant Chemoradiotherapy with Cisplatin and Docetaxel in Patients with Locally Advanced Squamous Cell Head and Neck Cancers

    Asian Pacific Journal of Cancer Prevention, 2013

    DOI 10.7314/apjcp.2013.14.4.2557 PMID 23725174 11 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  15. Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers

    Tumori Journal, 2013

    DOI 10.1177/030089161309900405 PMID 24326834 3 citations (OpenAlex) Source : OpenAlex

  16. Meetings and Conferences · Tagungen und Kongresse

    Breast Care, 2013

    DOI 10.1159/000170971 Texte intégral en libre accèsSource : OpenAlex

  17. Prognostic significance of presence of any mucinous component in curatively resected stage II and III colorectal cancer patients who received adjuvant treatments: Data from a single tertiary center.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14660 Texte intégral en libre accèsSource : OpenAlex

  18. Journal Club

    Breast Care, 2013

    DOI 10.1159/000348467 Texte intégral en libre accèsSource : OpenAlex

  19. PharmaNews / PharmaTicker

    Breast Care, 2013

    DOI 10.1159/000233219 Texte intégral en libre accèsSource : OpenAlex

  20. Guidelines for Authors

    Breast Care, 2013

    DOI 10.1159/000312579 Source : OpenAlex

  21. The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.

    Çanakkale Onsekiz Mart University AVESIS, 2013

    Source : OpenAlex

  22. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

    Journal of Clinical Oncology, 2012

    DOI 10.1200/jco.2012.30.15_suppl.e16015 Texte intégral en libre accèsSource : OpenAlex

  23. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

    Kocaeli Üniversitesi - AVESİS, 2012

    Source : OpenAlex

  24. Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer

    Biomarkers, 2012

    DOI 10.3109/1354750x.2012.738250 PMID 23116493 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  25. The Prognostic Significance of Tymidine Kinase Activity Levels in Metastatic Colorectal Cancer

    Annals of Oncology, 2012

    DOI 10.1016/s0923-7534(20)33117-3 Texte intégral en libre accèsSource : OpenAlex

  26. Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

    Oncology, 2012

    DOI 10.1159/000342429 PMID 23076023 16 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  27. Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study (Anatolian Society of Medical Oncology)

    Neoplasma, 2012

    DOI 10.4149/neo_2012_038 PMID 22329849 12 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  28. Klasik kaposi sarkomlu 156 vaka : Kliniko-epidemiyolojik özellikler (ATOD ÇALIŞMASI)

    Çanakkale Onsekiz Mart University AVESIS, 2012

    Source : OpenAlex

  29. Long Term Survivors with Metastatic Pancreatic Cancer Treated with Gemcitabine Alone or Plus Cisplatin: a Retrospective Analysis of an Anatolian Society of Medical Oncology Multicenter Study

    Asian Pacific Journal of Cancer Prevention, 2012

    DOI 10.7314/apjcp.2012.13.5.1841 PMID 22901133 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  30. False Positive FDG PET/CT Resulting from Fibrous Dysplasia of the Bone in the Work-Up of a Patient with Bladder Cancer: Case Report and Review of the Literature.

    Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society, 2012

    DOI 10.5812/iranjradiol.10303 PMID 23599713 9 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  31. 99mTc-MDP- and 18F-FDG-avid metastatic liver lesion: the similarities and differences between 2 modalities.

    Clinical nuclear medicine, 2012

    DOI 10.1097/rlu.0b013e318238f53f PMID 22391711 Source : ORCID

  32. Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience

    Onkologie, 2012

    DOI 10.1159/000345040 PMID 23207619 19 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  33. Adjuvant Chemoradiation for Gastric Cancer: Multicentric Study of the Anatolian Society of Medical Oncology

    Hepatogastroenterology, 2012

    DOI 10.5754/hge11709 PMID 22389301 4 citations (OpenAlex) Source : OpenAlex

  34. Abstract OT1-1-08: Clinical outcomes among ErbB2+ MBC patients treated with lapatinib-capecitabine after trastuzumab progression: Role of early switch to lapatinib (TYCO study).

    Cancer Research, 2012

    DOI 10.1158/0008-5472.sabcs12-ot1-1-08 Source : OpenAlex

  35. Prognostic analysis of the patients with operable gastric cancer and the importance of tolerability of therapy: Study of Anatolian Society of Medical Oncology.

    Journal of Clinical Oncology, 2012

    DOI 10.1200/jco.2012.30.15_suppl.e14526 Texte intégral en libre accèsSource : OpenAlex

  36. Gemcitabine and Cisplatin Combination Chemotherapy in Triple Negative Metastatic Breast Cancer Previously Treated with a Taxane/Anthracycline Chemotherapy; Multicenter Experience

    Neoplasma, 2012

    DOI 10.4149/neo_2012_005 PMID 22103897 25 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  37. The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens

    Journal of Chemotherapy, 2012

    DOI 10.1179/1973947812y.0000000020 PMID 23040686 10 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  38. Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer

    Journal of Cancer Research and Clinical Oncology, 2012

    DOI 10.1007/s00432-012-1264-5 PMID 22722713 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  39. Bevacizumab (BEV) plus capecitabine as maintenance therapy after initial treatment with BEV plus XELOX in previously untreated patients (pts) with metastatic colorectal cancer (mCRC): Mature data from STOP and GO, a phase III, randomized, multicenter study.

    Journal of Clinical Oncology, 2012

    DOI 10.1200/jco.2012.30.15_suppl.3565 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  40. Mide Kanserinde Adjuvan Sistemik Tedavi

    Turkiye Klinikleri Medical Oncology - Special Topics, 2012

    Source : OpenAlex

  41. Lokal ileri evre özefagus kanserinde kemoradyoterapi deneyimimiz

    DergiPark (Istanbul University), 2012

    Texte intégral en libre accèsSource : OpenAlex

  42. Prognostic Significance of Combined Positivity of Lymphatic, Vascular, and Perineural Invasion (TRIPLE POSITIVE) in Stage II/III Colorectal Cancer; A New Paradigm Worth to Investigate?

    Annals of Oncology, 2012

    DOI 10.1016/s0923-7534(20)33155-0 Texte intégral en libre accèsSource : OpenAlex

  43. Prognostic Factors in Development of Brain Metastasis in Stage III Non-Small Cell Lung Cancer Patients After Definitive Treatment

    Annals of Oncology, 2012

    DOI 10.1016/s0923-7534(20)33760-1 Texte intégral en libre accèsSource : OpenAlex

  44. Nüks yüksek gradli glial tümörlerde bevasizumabin sağkalim üzerine etkisi

    Dspace Repository (Marmara Üniversitesi), 2012

    Texte intégral en libre accèsSource : OpenAlex

  45. Rektum kanserinin adjuvan tedavisinde oral floropirimidin folinik asitle eş zamanli radyoterapi uygulamasinin yaşam kalitesine etkisi

    Dspace Repository (Marmara Üniversitesi), 2012

    Texte intégral en libre accèsSource : OpenAlex

  46. metastatik kolorektal kanserli hastalarda Bevasizumab kombinasyonlu kemoterapi rejimlerinin ikinci ve sonraki basamaklarda etkinlik ve tolerabilitesinin reyropektif olarak değerlendirilmesi:ATOD deneyimi

    Çanakkale Onsekiz Mart University AVESIS, 2012

    Source : OpenAlex

  47. Kanser tanisi alan hastalarda poliklinik şartlarinda üç farkli test Ile nütrisyonel durum değerlendirmesi

    Dspace Repository (Marmara Üniversitesi), 2012

    Source : OpenAlex

  48. Co-existence of gastrointestinal stromal tumors with other primary neoplasms.

    PubMed, 2011

    PMID 21830398 13 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  49. Primary breast mantle cell lymphoma with atypical relapse patterns.

    PubMed, 2011

    PMID 21674874 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  50. Is Subdivision of pT2 Tumors Superior to Lymph Node Metastasis for Predicting Survival of Patients with Gastric Cancer? Review of 224 Patients from Four Centers

    Digestive Diseases and Sciences, 2011

    DOI 10.1007/s10620-011-1721-z PMID 21660487 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex